검색어 : 통합검색[330.1]
총 7,239건 중 1,000건 출력
, 10/100 페이지
-
91
- MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting <i>CELF1</i>
- Wang, Hongbin; Liu, Guijing; Li, Tao; Wang, Naizhu; Wu, Jingkun; Zhi, Hua; Department of Neurosurgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China; Department of Cardiology, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China; Department of Neurosurgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China; Department of Neurosurgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China; Department of Neurosurgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China; Department of Cardiology, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China; (Archives of medical science : AMS, v.16, 2020, pp.1166-1175)
-
92
- 330. Usefulness of MR for radiation therapy : Evaluation of acute radiation damage of human brain by ^1H-MRS
- ; ; (日本放射線技術學會雜誌 = Japanese journal of radiological technology, v.49, 1993, pp.509)
-
93
- Lexicon of Jewish Names in Late Antiquity: Part 1, Palestine 330 BCE-200 CE
- Kern-Ulmer, Rivka B.; Ilan, Tal; ; (Journal of Biblical literature, v.124, 2005, pp.376)
-
94
- 1.P.330 Anthropometry and lipoproteins-related characteristics of young adult males in Taiwan
- Ding, Y.A.; Chu, N.F.; Wang, T.W.; Lin, C.C.; ; (Atherosclerosis, v.134, 1997, pp.86-86)
-
95
- Kuraya Sanseido Aims at Consolidated Sales of Yen1,330 Bil. in FY2004
- ; ; (Pharma Japan: Japan drug industry news, v.1786, 2002, pp.4)
-
96
- Die Reform des § 1 AStG - Ergänzende Anmerkungen zu Greil/Saliger, ISR 2021, 330 ff.
- Rasch, Stephan; ; (Internationale Steuer-Rundschau : Zeitschrift fuer Internationales Steuerrecht, v.10, 2021, pp.336-338)
-
97
- Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes
- Moestrup, S.K.; Nielsen, S.; Andreasen, P.; Jørgensen, K.E.; Nykjaer, A.; Røigaard, H.; Gliemann, J.; Christensen, E.I.; ; (The Journal of biological chemistry, v.268, 1993, pp.16564-16570)
-
98
- 1P-330 Monodisperse Semi-Permeable Microcapsules for Biochemical Assay(The 46th Annual Meeting of the Biophysical Society of Japan)
- Adachi, Aki; Morimoto, Yuya; Takeuchi, Shoji; Institute of Industrial Science, the University of Tokyo; Institute of Industrial Science, the University of Tokyo; Institute of Industrial Science, the University of Tokyo:PRESTO, JST; (生物物理 = Biophysics, v.48, 2008, pp.S73)
-
99
- BMI1 as a Potential Target of miR-330-3p in Colorectal Cancer
- Soheilifar, Mohammad Hasan; Moshtaghian, Abdolvahab; Amini, Razieh; Asefi, Masoud; Basiri, Parviz; Saidijam, Massoud; ; (Middle east journal of rehabilitation and health, v.5, 2018, )
-
100
- KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
- Gravina, Giovanni Luca; Mancini, Andrea; Sanita, Patrizia; Vitale, Flora; Marampon, Francesco; Ventura, Luca; Landesman, Yosef; McCauley, Dilara; Kauffman, Michael; Shacham, Sharon; Festuccia, Claudio; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy; Pathology Division, San Salvatore Hospital, L’Aquila, Italy; Karyopharm Therapeutics, Newton, MA USA; Karyopharm Therapeutics, Newton, MA USA; Karyopharm Therapeutics, Newton, MA USA; Karyopharm Therapeutics, Newton, MA USA; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology; (BMC cancer, v.15, 2015, pp.941)
QUICK MENU
